Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease
- 1 April 1982
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 49 (5) , 1267-1269
- https://doi.org/10.1016/0002-9149(82)90054-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 11. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experienceAmerican Heart Journal, 1980
- Treatment of severe hypertension by repeated bolus injections of labetalol.British Journal of Clinical Pharmacology, 1979
- Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.Published by Wiley ,1979
- Labetalol infusion in acute myocardial infarction with systemic hypertension.Published by Wiley ,1979
- Coronary artery spasm during exercise in patients with variant angina.Circulation, 1979
- “Variant” angina: One aspect of a continuous spectrum of vasospastic myocardial ischemiaThe American Journal of Cardiology, 1978
- Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patientsAmerican Heart Journal, 1977
- Reflex Increase in Coronary Vascular Resistance in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1976
- The effects of a new α‐ and β‐adrenoceptor antagonist (AH5158) upon the general and coronary haemodynamics of intact dogsBritish Journal of Pharmacology, 1973
- Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in ManCirculation, 1971